Cellular signaling can inhibit the membrane Na؉ -K ؉ pump via protein kinase C (PKC)-dependent activation of NADPH oxidase and a downstream oxidative modification, glutathionylation, of the  1 subunit of the pump ␣/ heterodimer. It is firmly established that cAMP-dependent signaling also regulates the pump, and we have now examined the hypothesis that such regulation can be mediated by glutathionylation. Exposure of rabbit cardiac myocytes to the adenylyl cyclase activator forskolin increased the co-immunoprecipitation of NADPH oxidase subunits p47 phox and p22 phox , required for its activation, and increased superoxide-sensitive fluorescence. Forskolin also increased glutathionylation of the Na ؉ -K ؉ pump  1 subunit and decreased its co-immunoprecipitation with the ␣ 1 subunit, findings similar to those already established for PKC-dependent signaling. The decrease in co-immunoprecipitation indicates a decrease in the ␣ 1 / 1 subunit interaction known to be critical for pump function. In agreement with this, forskolin decreased ouabain-sensitive electrogenic Na ؉ -K ؉ pump current (arising from the 3:2 Na ؉ :K ؉ exchange ratio) of voltage-clamped, internally perfused myocytes. The decrease was abolished by the inclusion of superoxide dismutase, the inhibitory peptide for the ⑀-isoform of PKC or inhibitory peptide for NADPH oxidase in patch pipette solutions that perfuse the intracellular compartment. Pump inhibition was also abolished by inhibitors of protein kinase A and phospholipase C. We conclude that cAMPand PKC-dependent inhibition of the cardiac Na ؉ -K ؉ pump occurs via a shared downstream oxidative signaling pathway involving NADPH oxidase activation and glutathionylation of the pump  1 subunit.